KKR offers $1.2bn to buy Swedish life sciences group Biotage
Private equity firm KKR has offered to buy all shares in Swedish life sciences company Biotage for Skr11.6bn ($1.2bn).
The public cash offer, via a newly formed company by KKR called RWK BidCo, is for Skr145 per share in Biotage. The offer, made on 22 April, represents a 60.1% premium on the life science group's last closing share price on 17 April.
Shares in Stockholm-listed Biotage surged 36% at market open on 22 April following the offer. The company has a market cap of $1.2bn.
Based on a full evaluation and assessment of the US private equity firm's takeover bid, Biotage's board has recommended to shareholders that the offer be accepted.
The deal comes amid a dry patch for mergers and acquisitions involving US equity due to US President Donald Trump's tariff policy, however KKR seems to be bucking that trend. The firm stuck another sizeable healthcare deal recently, agreeing to acquire E45 maker Karo Healthcare – also Stockholm-based – for €2.6bn ($3bn) earlier in April.
Biotage develops products used in drug discovery and development, including synthesisers, purification systems, and evaporators, amongst others. It also provides products for clinical and bioanalytical testing and toxicology.
KKR already owns a 17% stake in Biotage through Gamma Biosciences, a life sciences tool investment platform it created in 2019. It soon could have full ownership of a company that struggled financially in the past year.
Releasing its interim Q1 report on the same day, Biotage reported a sales decrease of nearly 20% compared to the same period in 2024. The life sciences group has previously highlighted the volatility within the bioprocessing market. Other big companies such as Merck's life science division MilliporeSigma has also felt the effects of the sector's low customer numbers.
Despite Biotage seeing stronger demand in the drug discovery segment and peptide system manufacturing, the company deemed KKR as having 'the potential to leverage its network of industrial advisers to accelerate the company's scale-up in a private setting in the years ahead.'
Although the board admitted it sees additional value held by Biotage that is not fully reflected in KKR's offer, it 'recognises that there are risks related thereto and the associated short-term volatility'.
Biotage's CEO Frederic Vanderhaegen said in a statement following the Q1 results: 'We remain confident in our future mid to long-term outlook while managing the short-term headwinds with a right-sized cost base.'
"KKR offers $1.2bn to buy Swedish life sciences group Biotage" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
12 minutes ago
- Bloomberg
US Inflation Beats Estimates for a Fourth Month
For four months many economists have predicted that US inflation would reignite, in large part due to President Donald Trump's trade war and the knock-on effects his tariffs would have on the economy. But for a fourth month in a row, data released by the Trump administration's Bureau of Labor Statistics came in lower than expected. The consumer price index, excluding the often volatile food and energy categories, increased only 0.1% from April, according to government data. The string of below-forecast inflation readings could be attributable to how many of the administration's threatened levies are on hold. (In early April, Trump's 'reciprocal' tariffs managed to destabilize the bond market before he largely retreated.) Treasury Secretary Scott Bessent, who is being floated as a potential replacement for Jerome Powell at the Federal Reserve, credited Trump's trade policies for slowing inflation, saying he challenged a 'decades-old status quo.'
Yahoo
13 minutes ago
- Yahoo
S&P 500 ends lower; traders focus on Middle East tension
STORY: U.S. stocks ended lower on Wednesday, with the Dow unchanged, the S&P 500 slipping a quarter of one percent, and the Nasdaq losing half of one percent. Wall Street erased modest gains as tensions flared in the Middle East. Sources said the U.S. was preparing a partial evacuation of its embassy in Iraq, after a senior Iranian official said Tehran will strike U.S. bases in the region if nuclear negotiations fail and if conflict arises with the United States. Investors also awaited more details on trade talks between the U.S. and China after President Donald Trump said a deal was (quote) "done," with Beijing to supply magnets and rare earth minerals. But amid the trade developments and geopolitical tensions, BMO Chief Market Strategist Carol Schleif says the stock market continues to show resilience. 'It's clearly a market that wants to look through the short term, whether it's exhausted or not, but it wants to look through short term noise and and stick with the long term fundamentals. And the fact is is the fundamentals keep coming through solidly. You know people thought we'd see more inflation out of today's CPI report and it's not being passed on. I think companies are either- They either stocked up, they're figuring out how to absorb some of it or and or they understand that consumers are just the consumers, have had it with inflation. And so, there's a big risk to passing it on.' The latest data on consumer prices showed they increased only marginally in May, while economists expect inflation to accelerate in the coming months due to the Trump administration's import tariffs. Stocks on the move Wednesday included GameStop which fell more than 5% after the video game retailer reported a decline in first-quarter revenue. And shares of Starbucks added more than 4% after its CEO told the Financial Times that it received 'a lot of interest' for its China business. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
23 minutes ago
- Yahoo
Trump is expected to sign a measure blocking California's nation-leading vehicle emissions rules
WASHINGTON (AP) — President Donald Trump is expected to sign a measure Thursday that blocks California's first-in-the-nation rule banning the sale of new gas-powered cars by 2035, a White House official told The Associated Press. The resolution Trump plans to sign, which Congress approved last month, aims to quash the country's most aggressive attempt to phase out gas-powered cars. He also plans to approve measures to overturn state policies curbing tailpipe emissions in certain vehicles and smog-forming nitrogen oxide pollution from trucks. The timing of the signing was confirmed Wednesday by a White House official who spoke on condition of anonymity to share plans not yet public. The development comes as the Republican president is mired in a clash with California's Democratic governor, Gavin Newsom, over Trump's move to deploy troops to Los Angeles in response to immigration protests. It's the latest in an ongoing battle between the Trump administration and heavily Democratic California over everything from tariffs to the rights of LGBTQ+ youth and funding for electric vehicle chargers. According to the official, Trump is expected to sign resolutions that block California's rule phasing out gas-powered cars and ending the sale of new ones by 2035. He will also kill rules that phase out the sale of medium- and heavy-duty diesel vehicles and cut tailpipe emissions from trucks. The president is scheduled to sign the measures and make remarks during an event at the White House on Thursday morning. Newsom, who is considered a likely 2028 Democratic presidential candidate, and California officials contend that what the federal government is doing is illegal and said the state plans to sue. Transportation Secretary Sean Duffy, Energy Secretary Chris Wright and Environmental Protection Agency Administrator Lee Zeldin are expected to attend, along with members of Congress and representatives from the energy, trucking and gas station industries. California, which has some of the nation's worst air pollution, has been able to seek waivers for decades from the EPA allowing it to adopt stricter emissions standards than the federal government. In his first term, Trump revoked California's ability to enforce its standards, but President Joe Biden reinstated it in 2022. Trump has not yet sought to revoke it again. Republicans have long criticized those waivers and earlier this year opted to use the Congressional Review Act, a law aimed at improving congressional oversight of actions by federal agencies, to try to block the rules. That's despite a finding from the U.S. Government Accountability Office, a nonpartisan congressional watchdog, that California's standards cannot legally be blocked using the Congressional Review Act. The Senate parliamentarian agreed with that finding. California, which makes up roughly 11% of the U.S. car market, has significant power to sway trends in the auto industry. About a dozen states signed on to adopt California's rule phasing out the sale of new gas-powered cars. The National Automobile Dealers Association supported the federal government's move to block California's ban on gas-powered cars, saying Congress should decide on such a national issue, not the state. The American Trucking Associations said the rules were not feasible and celebrated Congress' move to block them. Chris Spear, the CEO of the American Trucking Associations, said in a statement Wednesday: 'This is not the United States of California.' ___ Austin reported from Sacramento, Calif.
